title: [Intravitreal bevacizumab for choroidal neovascularization associated with Best's disease].
abstract: METHODS
  A 27-year old woman presented with loss of vision in the right eye (20/200). Ophthalmoscopic examination showed intrarretinal hemorrhage in the macular region with neurosensory detachment in the right eye, and viteliform deposit on the left eye. Fluorescein angiography and the electrooculogram confirmed the diagnosis of choroidal neovascularization associated with Best's disease. Four weeks after a single bevacizumab intravitreal injection, visual acuity was restored (20/25) and remained stable after a 12 month follow-up.
  
  
  CONCLUSIONS
  Intravitreal bevacizumab appears to be an effective treatment for choroidal neovascularization associated to Best's disease.
authors: Servicio de Oftalmología, Hospital Vall d'Hebrón, Barcelona, España. Electronic address: dvvilloria@alumni.unav.es.
authors: D
authors: D
authors: Velazquez-Villoria
authors: Servicio de Oftalmología, Hospital Vall d'Hebrón, Barcelona, España.
authors: C
authors: C
authors: Macià Badia
authors: Servicio de Oftalmología, Hospital Vall d'Hebrón, Barcelona, España.
authors: J
authors: J
authors: Rigo Quera
authors: Servicio de Oftalmología, Hospital Vall d'Hebrón, Barcelona, España.
authors: L
authors: L
authors: Velez-Escola
authors: Servicio de Oftalmología, Hospital Vall d'Hebrón, Barcelona, España.
authors: G
authors: G
authors: Arcos-Algaba
authors: Servicio de Oftalmología, Hospital Vall d'Hebrón, Barcelona, España.
authors: V
authors: V
authors: Martínez-Castillo
authors: Servicio de Oftalmología, Hospital Vall d'Hebrón, Barcelona, España.
authors: J
authors: J
authors: García-Arumí
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000068258:Bevacizumab / Q000008:administration & dosage*; D020256:Choroidal Neovascularization / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D057826:Vitelliform Macular Dystrophy / Q000150:complications*
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab
keywords: Best's disease; Best's vitelliform macular dystrophy; Bevacizumab; Choroidal neovascularization; Distrofia macular viteliforme de Best; Enfermedad de Best; Intravitreal injection; Inyección intravítrea; Neovascularización coroidea